Business
Press Release Sep 20 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 20, 2023, titled "Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 20, 2023, titled \"Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%\". View Attachment","length":351,"tagName":"div"}]